Induction of macrophage foam cell formation by Chlamydia pneumoniae

Journal of Infectious Diseases

Volumn 177, Issue 3, 1998, Pages 725-729

  Kalayoglu, Murat V ^a   Byrne, Gerald I ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BUTYLCRESOL; FUCOIDIN; HEPARIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL;

EID: 0031912008     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514241     Document Type: Article

References (26)

1. McMillan G. Historical review of research on atherosclerosis. Adv Exp Med Biol 1995;369:1-6.
2. Gofman J, Lindgren F, Elliott H. The role of lipids and lipoproteins in atherosclerosis. Science 1950;111:166-71.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
4. Brown M, Goldstein J. Lipoprotein metabolism in the macrophage. Annu Rev Biochem 1983;52:223-61.
5. Goldstein J, Brown M. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977;46:897-930.
6. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
7. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
8. Mendall M, Patel P, Ballam L, Strachan D, Northfield T. C-reactive protein and its relation to cardiovascular risk factors - a population based cross sectional study. Br Med J 1996;312:1061-5.
9. Campbell L, O'Brien E, Cappuccio A, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
10. Kuo C, Shor A, Campbell L, Fukushi H, Patton D, Grayston T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
11. Ramirez J, Ahkee S, Summersgill J, et al. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979-82.
12. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
13. Gupta S, Leatham E, Carrington D, Mendall M, Kaski J, Camm J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96: 404-7.
14. Redgrave T, Roberts D, West C. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 1975;65:42-9.
15. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992-13:341-90.
16. Caldwell H, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981;31:1161-76.
17. Garner B, Baoutina A, Dean R, Jessup W. Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity, and LDL receptor-related protein expression. Atherosclerosis 1997;128:47-58.
18. Schaffner T, Taylor K, Bartucci E, et al. Arterial foam cells with distinctive immunomorphologic and histochcmical features of macrophages. Am J Pathol 1980;100:57-80.
19. Huh H, Pearce S, Yesner L, Schindler J, Silverstein R. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996;87:2020-8.
20. Gamble W, Vaughan M, Kruth H, Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978;19:1068-70.
21. Aviram M. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 1996;34:599-608.
22. Lopes-Virella M, Klein R, Stevenson H. Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis 1987;7:176-84.
23. Van Lenten B, Fogelman A, Seager J, Ribi E, Haberland M, Edwards P. Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J Immunol 1985; 134:3718-21.
24. Kaukoranta-Tolvanen S, Teppo A, Kaitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996;21:215-21.
25. Stopeck A, Nicholson A, Mancini F, Hajjar D. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 1993;268:17489-94.
26. Moulder J. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991;55:143-90.